AbbVie Buys Out Allergan

AbbVie and Allergan Strike $63 Billion Deal

The drug maker AbbVie said on Tuesday that it planned to buy Allergan, the maker of Botox, for about $63 billion, in one of the biggest mergers in the health care industry this year...